ArticleSurgical neurology international2026
Safety and efficacy of tranexamic acid and beta-blockers for traumatic brain injury: A systematical review and meta-analysis.
Article in Surgical neurology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Intracranial hemorrhage is a leading cause of secondary brain injury following traumatic brain injury (TBI). Tranexamic acid (TXA), an antifibrinolytic agent, is recommended by Advanced Trauma Life Support for hemorrhagic trauma, but its role in TBI remains debated. Recent meta-analyses and randomized controlled trials (RCTs) have demonstrated conflicting results regarding TXA's mortality benefits, while beta-blockers (BBs) show potential in mitigating hyperadrenergic states post-TBI. This study aims to update the evidence on TXA and BB administration in TBI by incorporating newer RCTs and systematic reviews published post-February 2023. Methods: A systematic search of PubMed, ScienceDirect, and clinicaltrials.gov was conducted using keywords: "tranexamic acid," "beta blockers," and "traumatic brain injury." Studies published up to December 2024 were included to address gaps in the literature. Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed, and data were analyzed using RevMan 5. Primary outcomes were the safety and efficacy of TXA and BB. Results: Thirteen RCTs ( Conclusion: TXA and BB are safe but do not significantly improve mortality in TBI. Our updated analysis aligns with recent literature, underscoring the need for further RCTs to clarify subgroups (e.g., mild-moderate TBI) that may benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.